Annual Drug Patent Expirations for VTAMA
Vtama is a drug marketed by Dermavant Sci and is included in one NDA. There are three patents protecting this drug.
This drug has fifty patent family members in thirty-three countries.
The generic ingredient in VTAMA is tapinarof. Additional details are available on the tapinarof profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
